Exicure, Inc.
XCUR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001698530
No open-market purchases or sales by Exicure, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $306.0K in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Exicure, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −1 vs. Q3 2023
- Shares held
- 587.1K
- −69.1K (−10.5%) vs. Q3 2023
- Total value
- $342.0K
- −$128.2K (−27.3%) vs. Q3 2023
- New holders
- 3
- 2 more added
- Sold out
- 4
- 6 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XCUR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $306.0K |
| Q1 2026 | 19 | $731.4K |
| Q4 2025 | 15 | $803.0K |
| Q3 2025 | 13 | $1.58M |
| Q2 2025 | 15 | $2.62M |
| Q1 2025 | 13 | $4.26M |
| Q4 2024 | 12 | $4.21M |
| Q3 2024 | 12 | $127.3K |
| Q2 2024 | 16 | $171.6K |
| Q1 2024 | 20 | $368.4K |
| Q4 2023 | 16 | $342.0K |
| Q3 2023 | 17 | $470.1K |
| Q2 2023 | 15 | $854.3K |
| Q1 2023 | 15 | $594.1K |
| Q4 2022 | 16 | $898.5K |
| Q3 2022 | 18 | $1.12M |
| Q2 2022 | 18 | $1.56M |
| Q1 2022 | 43 | $5.12M |
| Q4 2021 | 48 | $8.49M |
| Q3 2021 | 47 | $34.9M |
| Q2 2021 | 58 | $44.4M |
| Q1 2021 | 72 | $68.2M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Exicure, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 93 | $0 | 0.00% | −213−69.6% | Reduced |
| JPMorgan Chase & Co | 10 | $6 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 60 | $35 | 0.00% | +3+5.3% | Added |
| Advisor Group Holdings, Inc. | 289 | $166 | 0.00% | −143−33.1% | Reduced |
| UBS Group AG | 1,707 | $990 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3,271 | $1.90K | 0.00% | −92−2.7% | Reduced |
| BlackRock Inc. | 5,125 | $2.97K | 0.00% | −7,249−58.6% | Reduced |
| Tower Research Capital LLC (TRC) | 6,973 | $4.04K | 0.00% | −19−0.3% | Reduced |
| Two Sigma Securities, LLC | 16,726 | $9.71K | 0.00% | +16,726 | New |
| Virtu Financial LLC | 18,674 | $11.0K | 0.00% | +18,674 | New |
| Vanguard Group Inc | 40,093 | $23.3K | 0.00% | +4,975+14.2% | Added |
| Renaissance Technologies LLC | 49,500 | $29.0K | 0.00% | −8,500−14.7% | Reduced |
| Northwestern University | 52,145 | $30.0K | 0.03% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 52,996 | $31.3K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 57,815 | $34.2K | 0.00% | +57,815 | New |
| Carlyle Group Inc. | 281,636 | $163.4K | 0.01% | 00.0% | Unchanged |
| Carlson Capital L P | 0 | $0 | 0.00% | −114,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −20,883−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −16,192−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |